"Link ID","Source name","Source Display Name","Source type","Target name","Target Display Name","Target type","Confidence","Documents","Document IDs","Relationships"
"0","F2","F2","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","86.33940093719002","12","Patent_WO2003083490A2,Patent_EP1436628A2,Medline_9733155,Medline_12404033,Medline_9734636,Medline_22690563,Medline_11739542,Medline_19920091,Medline_22635224,Pmcoa_4389016,Medline_22635235,Medline_15751817","Prepositional,Association"
"2","F12","F12","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","78.39779795417729","5","Pmcoa_1322227,Medline_15869593,Medline_10997986,Medline_11916074,Medline_16324213","Prepositional"
"4","APOH","APOH","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","81.92134691988406","35","Medline_19706343,Medline_20876187,Pmcoa_4975233,Patent_WO2011022780A1,Patent_EP1853631A2,Patent_US20050107584,Patent_US7053178,Medline_11019958,Medline_9825748,Pmcoa_3328749,Pmcoa_1794526,Medline_15507263,Medline_15507279,Medline_12209489,Patent_US20060228299,Medline_21757614,Medline_12096042,Medline_8589206,Medline_14768953,Medline_10192506,Medline_9933445,Medline_16539279,Pmcoa_3002267,Pmcoa_3316958,Medline_17894014,Patent_US20090202980,Patent_US20070003552,Medline_15990076,Medline_16325497,Medline_12648080,Medline_16038107,Pmcoa_2653525,Medline_9276526,Pmcoa_3273179,Medline_17265495","sialylation,Binding,AssociationPositive,Association,Prepositional,Part_Of,nitration,Regulation"
"5","ANXA2","ANXA2","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","76.5206417812914","3","Medline_18322784,Medline_22939813,Medline_20229030","Prepositional"
"7","F3","F3","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","83.9248412112728","11","Medline_15456541,Medline_8420328,Medline_16385547,Medline_18827061,Medline_9031483,Medline_12730514,Pmcoa_3173726,Pmcoa_2656223,Medline_19556010,Pmcoa_3176495,Medline_16968331","Prepositional,GeneExpression,Regulation,AssociationNegative,Association"
"9","RITUXIMAB","RITUXIMAB","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","92.84117538665642","6","Medline_20425532,Medline_21993385,Medline_12967521,Medline_18089684,Pmcoa_3238310,Medline_16465669","Prepositional,Treat"
"10","GPI","GPI","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","80.06131402927672","21","Medline_10852267,Medline_20876187,Medline_21535391,Medline_21618459,Patent_US8338117,Patent_US20040241858,Patent_US7745146,Medline_15762889,Medline_10680749,Pmcoa_3523136,Patent_US7160733,Medline_17332980,Medline_10563468,Patent_EP1910844B1,Patent_US20080207488,Patent_WO2007008069A2,Patent_EP1910842A2,Patent_EP2386861A2,Patent_US20080118529,Patent_US20080267948,Medline_19758240","Prepositional,Binding,Association,AssociationPositive,AssociationNegative"
"11","CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O","WARFARIN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","91.71215224734944","18","Medline_13679527,Medline_8730144,Medline_14699652,Pmcoa_2632629,Medline_14695423,Medline_14699650,Medline_8952760,Medline_17531168,Medline_11705531,Medline_17440049,Medline_20425536,Medline_14699651,Medline_15693072,Medline_17489989,Medline_21606873,Medline_20704100,Medline_12322801,Medline_7933603","Prepositional,AssociationPositive,Treat"
"14","CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2O\C(C[C@H]12)=C/CCCC(O)=O","EPOPROSTENOL","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","80.11251101330096","2","Medline_8315831,Medline_3296970","Prepositional"
"15","CD79A","CD79A","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","79.22363286077582","2","Medline_9646856,Pmcoa_4975233","Prepositional,AssociationPositive"
"16","TNF","TNF","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","86.76284721480505","7","Medline_11246532,Patent_EP1601682A2,Medline_12892396,Patent_WO2004080273A2,Patent_US20060193863,Patent_EP1601682B1,Medline_20337548","Prepositional,AssociationNegative,AssociationPositive"
"17","CCCCCCCCCCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(C)=O","PLATELET ACTIVATING FACTOR","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","68.20795712862979","4","Medline_10886305,Patent_WO2009056826A1,Patent_EP2217280A1,Patent_US20100278836","Prepositional"
"18","ANXA5","ANXA5","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","78.5552060822201","2","Medline_10522297,Medline_11108960","AssociationNegative,Prepositional"
"21","CC(=O)Oc1ccccc1C(O)=O","ASPIRIN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","91.3496567501396","16","Medline_7674234,Medline_20502298,Medline_10649166,Medline_8373524,Pmcoa_2679410,Medline_18308578,Medline_8371226,Medline_21640048,Pmcoa_2632629,Medline_8160462,Medline_20676893,Pmcoa_3524288,Medline_18089677,Medline_7804312,Medline_7933603,Medline_18043834","Regulation,Association,Prepositional,Treat,AssociationNegative"
"23","CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H](O)O[C@H](O[C@H]3[C@H](O)[C@@H](OS(O)(=O)=O)C(O)O[C@H]3C(O)=O)[C@H](OS(O)(=O)=O)[C@H]2CS(O)(=O)=O)O[C@@H]1C(O)=O","HEPARIN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","92.70093028681856","29","Medline_22122183,Medline_12661774,Medline_18275516,Pmcoa_3359668,Medline_12833567,Medline_20859172,Medline_20502298,Medline_22635233,Medline_21640048,Pmcoa_3277699,Medline_21206127,Medline_11711550,Medline_15307977,Medline_19716166,Pmcoa_3524288,Patent_US20070020647,Patent_EP2357257A1,Patent_US20090124542,Patent_US20090258822,Patent_US20090247451,Patent_US7745389,Patent_EP2302076A1,Patent_EP2377951A1,Patent_US8088579,Patent_EP2357254A1,Medline_15489858,Medline_11898913,Medline_7933603,Medline_18043834","Prepositional,RegulationPositive,Binding,Treat,Association,AssociationNegative,Regulation"
"24","DALTEPARIN","LOW MOLECULAR WEIGHT HEPARIN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","84.30365117050994","15","Medline_18308578,Pmcoa_3274119,Pmcoa_3277699,Medline_16412749,Pmcoa_3524288,Patent_US7745389,Patent_EP2302076A1,Patent_EP2357257A1,Patent_US20070020647,Patent_US20090124542,Patent_EP2377951A1,Patent_EP2357254A1,Patent_US8088579,Patent_US20090258822,Patent_US20090247451","Prepositional,Treat,AssociationNegative"
"25","CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CO[P@@](O)(=O)OCC(O)CO[P@](O)(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC","CARDIOLIPIN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","86.08220708164428","12","Pmcoa_1402286,Patent_WO2007016556A1,Medline_8217481,Medline_14598587,Medline_8025204,Patent_US7745146,Patent_US8338117,Medline_12121039,Patent_EP2380023A2,Patent_US20110250208,Patent_WO2011160845A2,Patent_WO2010069605A2","Prepositional,Association,AssociationPositive"
"26","CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12","PRAVASTATIN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","78.67469842171683","2","Patent_US20090312411,Patent_WO2009120413A2","AssociationNegative"
"29","F5","F5","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","79.76085783624006","4","Medline_19078479,Medline_22690563,Medline_12243558,Pmcoa_1936988","Prepositional"
"30","ClCCN(CCCl)P1(=O)NCCCO1","CYCLOPHOSPHAMIDE","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","72.13928699602229","2","Medline_12892393,Medline_12322801","Treat"
"32","C5AR1","C5AR1","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","77.67784309110016","6","Medline_14660741,Patent_EP2340028A1,Patent_WO2010039690A1,Patent_US20110269113,Patent_US20070123466,Medline_20005073","Regulation,Prepositional"
"34","CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12","SIMVASTATIN","DRUG","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","-1","2","Patent_WO2009120413A2,Patent_US20090312411","AssociationNegative"
"44","IGHM","IGHM","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","82.56169406088463","5","Pmcoa_2949716,Patent_US7053178,Patent_US6825319,Patent_US20050107584,Patent_WO2000001729A2","Prepositional"
"52","IS4","IS4","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","2.041514248805465","2","Patent_EP2331133A2,Patent_WO2010027501A2","Prepositional"
"57","F10","F10","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","77.87538780983378","2","Medline_17114499,Medline_8578503","Prepositional"
"68","TLR4","TLR4","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","71.77466650753892","2","Pmcoa_4389015,Medline_19614626","Prepositional,Treat"
"83","PROC","PROC","GENE","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","ANTI PHOSPHOLIPID ANTIBODY SYNDROME","CONDITION","78.17122934848992","2","Medline_22290026,Pmcoa_3494292","Prepositional"
